Vol 2022, No 2 (2022)

Table of Contents

Research & Development

Biogen Bets US$30 M on Genentech’s Lymphoma Bispecific Antibody Abstract pdf html
Lucy Haggerty
Janssen Bets US$1.4 B on Mersana’s ADC Platform Abstract pdf html
Ashish Tripathi
Amgen Delves into Protein Degrader Therapies with Plexium Collaboration Abstract pdf html
Sasha Yachu
Intellia and ONK Collaborate on CRISPR-Edited Cancer Cell Therapies Abstract pdf html
Lucy Haggerty
Curve Therapeutics Collaborates with Merck & Co. on Next Generation Drug Discovery Platform Abstract pdf html
Ayush Saxena & Lucy Haggerty

Mergers & Acquisitions

UCB Acquires Zogenix to Bolster its Epilepsy Portfolio Abstract pdf html
Ashish Tripathi
Equillium Acquires Bioniz Therapeutics to Strengthen Immunology Portfolio Abstract pdf html
Ayush Saxena & Lucy Haggerty


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.